Peptide News Digest

#Andrews-Research-Education-Foundation

1 story

Industry · View digest

Dr. James Andrews's Foundation and Vector Science Plan Clinical Programs for Peptides in Sports Injuries and Osteoarthritis

The Andrews Research & Education Foundation in Gulf Breeze, Florida, and Vector Science and Therapeutics of Mequon, Wisconsin, which is chaired by former HHS Secretary Tommy Thompson, said they will design and start clinical programs testing Vector's pharmaceutical-grade peptides for soft-tissue repair, muscle regeneration in aging athletes, and degenerative osteoarthritis. The release does not name the peptides, a trial start date, or funding, and it says the peptides may be investigational for these uses. The partners also plan peptide courses for sports medicine fellows and residents.